ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

April 11, 2003

CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule

May 9, 1986

NIH Panel Urges Wider Treatment of Hepatitis C

June 14, 2002

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

More Oncopathology Research Asked

June 30, 1978

NCI Budget for FY 1977 Would Halt New Research

January 23, 1976